In addition, survival analysis showed that cervical cancer patients with increased expression of METTL3 (Figure 7I), YTHDF3 (Figure 7J), and HDAC6 (Figure 7K) represented an obviously unsatisfied overall survival (OS). Here, METTL3 is linked to cervical carcinoma.